149 related articles for article (PubMed ID: 20075704)
1. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.
Trallero-Araguás E; Labrador-Horrillo M; Selva-O'Callaghan A; Martínez MA; Martínez-Gómez X; Palou E; Rodriguez-Sanchez JL; Vilardell-Tarrés M
Medicine (Baltimore); 2010 Jan; 89(1):47-52. PubMed ID: 20075704
[TBL] [Abstract][Full Text] [Related]
2. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
[TBL] [Abstract][Full Text] [Related]
3. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
4. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
5. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
7. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.
Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Balada E; Vilardell-Tarrés M; Juarez C
Ann Rheum Dis; 2012 Jun; 71(6):993-6. PubMed ID: 22294626
[TBL] [Abstract][Full Text] [Related]
8. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
[TBL] [Abstract][Full Text] [Related]
9. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
Espada G; Maldonado Cocco JA; Fertig N; Oddis CV
J Rheumatol; 2009 Nov; 36(11):2547-51. PubMed ID: 19833756
[TBL] [Abstract][Full Text] [Related]
11. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
12. Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.
Petri MH; Satoh M; Martin-Marquez BT; Vargas-Ramírez R; Jara LJ; Saavedra MA; Cruz-Gonzalez C; Andrade-Ortega L; Vera-Lastra O; Salazar-Páramo M; Prieto-Parra RE; Gonzalez-Lopez L; Gamez-Nava JI; Ramírez-Sánchez HU; Chan JY; Ross SJ; Chan EK; Vázquez-Del Mercado M
Arthritis Res Ther; 2013 Apr; 15(2):R48. PubMed ID: 23557279
[TBL] [Abstract][Full Text] [Related]
13. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
14. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.
Schiffenbauer A; Faghihi-Kashani S; O'Hanlon TP; Flegel WA; Adams SD; Targoff IN; Oddis CV; Ytterberg SR; Aggarwal R; Christopher-Stine L; Shamim EA; Dellaripa PF; Danoff SK; Mammen AL; Miller FW
Semin Arthritis Rheum; 2018 Dec; 48(3):504-512. PubMed ID: 29703532
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.
Trallero-Araguás E; Rodrigo-Pendás JÁ; Selva-O'Callaghan A; Martínez-Gómez X; Bosch X; Labrador-Horrillo M; Grau-Junyent JM; Vilardell-Tarrés M
Arthritis Rheum; 2012 Feb; 64(2):523-32. PubMed ID: 21953614
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.
Zhang L; Yang H; Yang H; Liu H; Tian X; Jiang W; Peng Q; Wang G; Lu X
Semin Arthritis Rheum; 2022 Aug; 55():152011. PubMed ID: 35489170
[TBL] [Abstract][Full Text] [Related]
20. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
